e-Health Program to Prevent Exacerbations in the Cystic Fibrosis Population

The goal of this clinical trial is to analyse the impact of a telematic assessment and monitoring protocol in people with cystic fibrosis, in order to identify exacerbations early, thus preventing loss of lung function and maintaining quality of life. Participants will be assigned to one of 3 study groups: Control group (CG-1): will receive their usual physiotherapy treatment; Treatment group (TG-2): will receive their usual physiotherapy treatment, plus explanation of the use of the monitoring equipment; Treatment and follow-up group (TGF-3): will receive their usual physiotherapy treatment, plus explanation of the use of the monitoring equipment, plus telematic control of exacerbations with feedback from the physiotherapist.

NCT Number	NCT06313827
Lead Sponsor	University of Valencia Collaborators: Asociación de Fibrosis Quística - Comunidad Valenciana
Conditions	Cystic Fibrosis
Enrollment	60 participants
Start Date	2024-10-01
Primary Completion	2026-01 (estimated)
Study Completion	2027-01 (estimated)
Updated on ClinicalTrials.gov	2025-02-13